GSK plc

Stocks

GSK

GB00BN7SWP63

Real-time Estimate Cboe Europe Other stock markets 11:12:12 2026-07-13 am EDT			5-day change	1st Jan Change
1,956.50 ^GBX	-0.25%		-1.31%	+7.26%

07:24am	GSK : UBS remains Neutral	ZD
05:59am	GSK Says Jemperli Poised to Transform Rectal Cancer Care After Positive Interim Trial Results	MT

Transcript : GSK plc - Special Call

Published on 05/28/2026 at 11:50 am EDT - Modified on 05/28/2026 at 03:35 pm EDT

S&P Capital IQ

Add MarketScreener to your sources

Presenter Speech
Constantin Fest (Executives)

Dear ladies and gentlemen, welcome to this GSK EASL presentation on Bepirovirsen B-Well 1 & 2 pivotal phase III studies. My name is Constantin from IR. I'm

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Add MarketScreener to your sources

Latest news about GSK plc

07:24am	GSK : UBS remains Neutral	ZD
05:59am	GSK Says Jemperli Poised to Transform Rectal Cancer Care After Positive Interim Trial Results	MT
05:09am	GSK Says Mid-Stage Trial of Jemperli Met Main Goal in Rectal Cancer	MT
04:33am	GSK posts encouraging data for bowel cancer treatment Jemperli	AN
04:16am	Oil gains lift BP as Iran tensions weigh	AN
03:14am	GSK's Jemperli meets main goal in mid-stage rectal cancer trial	RE
03:00am	GSK hails cancer trial success; Plus500 backs outlook	AN
02:33am	GSK Reports Positive Interim Data for Jemperli in Mid-stage Rectal Cancer Trial	MT
02:17am	GSK's cancer drug Jemperli meets main goal in mid-stage rectal cancer trial	RE
01:43am	GSK : JP Morgan remains a Sell rating	ZD
12:57am	UK Stocks-Factors to watch on July 13	RE
Jul. 10	GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial	AN
Jul. 10	GSK, Hansoh's targeted cancer drug hits main survival goal in China trial	RE
Jul. 10	GSK Licensor Hansoh Reports Positive Phase 3 Results for Risvutatug Rezetecan in China	MT
Jul. 10	GSK's Antibody-drug Conjugate for Small-cell Lung Cancer Meets Primary Endpoint in Late-stage China Study	MT